# Fragmentation of Elastin as a Biological Marker of Frailty and Impact in Tumor Progression in Elderly Patients With Cancer

> **NCT02807129** · NA · COMPLETED · sponsor: **CHU de Reims** · enrollment: 296 (actual)

## Conditions studied

- Cancer

## Interventions

- **BIOLOGICAL:** blood withdrawn
- **BIOLOGICAL:** urine collection

## Key facts

- **NCT ID:** NCT02807129
- **Lead sponsor:** CHU de Reims
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01-29
- **Primary completion:** 2023-01-16
- **Final completion:** 2023-01-16
- **Target enrollment:** 296 (ACTUAL)
- **Last updated:** 2026-01-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02807129

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02807129, "Fragmentation of Elastin as a Biological Marker of Frailty and Impact in Tumor Progression in Elderly Patients With Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02807129. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*